Drug‐induced vasculitis: Thiazide or the COVID‐19 vaccine, which one is guilty? A case report and literature review. Issue 6 (13th June 2022)

• Record Type: Journal Article
• Authors: Hekmat, Manoochehr; Jafari Naeini, Sepideh; Abbasi, Zahra; Dadkhahfar, Sahar
• Is Part Of: Clinical case reports. Volume 10:Issue 6(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-06-13
• Subjects: COVID‐19 vaccines -- thiazides -- vasculitis -- warfarin; Medicine -- Periodicals; 616.09
• DOI: 10.1002/ccr3.5978
• Languages: English
• ISSNs: 2050-0904

Abstract

Abstract: A middle‐aged woman with a history of COVID‐19 vaccine administration and valve replacement surgery was admitted with bilateral palpable purpuric lesions in the lower extremities and headache. Based on the initial diagnosis of vasculitis, corticosteroid therapy was initiated, which led to the resolution of skin lesions. Abstract : Drug‐induced vasculitis should be considered in the setting of vasculitis after the initiation of a new medication or the administration of COVID‐19 vaccines.